Analystreport

Gemphire Therapeutics Inc. (NASDAQ: GEMP) was given a new $31.00 price target on by analysts at Canaccord Genuity. They now have a "buy" rating on the stock.

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com